Tonix Pharmaceuticals Announces 1-for-100 Reverse Stock Split
Portfolio Pulse from
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) announced a 1-for-100 reverse stock split effective February 5, 2025. This move will consolidate shares, potentially impacting stock liquidity and price.
February 03, 2025 | 1:15 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Tonix Pharmaceuticals is implementing a 1-for-100 reverse stock split, effective February 5, 2025. This action will reduce the number of outstanding shares, which may affect the stock's liquidity and price.
A reverse stock split consolidates shares, which can lead to a higher stock price per share but may reduce liquidity. This is a significant corporate action for TNXP, directly affecting its stock structure.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100